Relationship of fatty liver with hypertension, hyperlipidemia, hyperglycemia among 1420 cases of physical examinees
X Chen
Abstract
X Chen
Abstract
Objective To investigate the relationship between fatty liver and hypertension, hyperlipidemia, hyperglycemia. Methods 1420 cases for medical examination from January 2013 to January 2014 in Physical Examination Center of General Hospital of PLA were selected as objects, of whom 211 cases of fatty liver were taken as fatty liver group, and the remaining 1209 cases of patients were taken as non-fatty liver group. The prevalence of hypertension,hyperlipidemia, hyperglycemia were compared. While FBG, TC, TG, HDL-C LDL-C, SBP, DBP, BMI levels were compared between the two groups. Results Among 1420 volunteers, 211 cases suffered with fatty liver, accounted for14.86%. 170 cases of male, the prevalence rate was 16.63%, 41 cases of female, the prevalence rate was 10.30%; the prevalence of fatty liver in males was significantly higher than female(χ2=13.478, P 0.05). Prevalence rates of fatty liver in males aged 30-40 and 40-50 were 20.00%, 20.14% retrospectively, significantly higher than other age groups(P 0.05); which in female aged 40-50, 50-60 were 12.67% and 11.58% retrospectively, significantly higher than other age groups(P 0.05). Incidence of hypertension, hyperlipidemia, hyperglycemia in fatty liver group were significantly higher than the non- fatty liver group, the differences were statistically significant between two groups(P 0.05). The FBG, TC, TG, LDL-C, SBP, DBP, BMI levels in fatty liver group were significantly higher than the non-fatty liver group, but the HDL-C level in the fatty liver group was lower, the differences were statistically significant(P 0.05). Conclusion Fatty liver has close relationship with hypertension, hyperlipidemia, hyperglycemia. These indicators should be combined analyzed in clinic, thus providing basis for guiding the development of integrated control measures.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the relationship between fatty liver and hypertension, hyperlipidemia, hyperglycemia. Methods 1420 cases for medical examination from January 2013 to January 2014 in Physical Examination Center of General Hospital of PLA were selected as objects, of whom 211 cases of fatty liver were taken as fatty liver group, and the remaining 1209 cases of patients were taken as non-fatty liver group. The prevalence of hypertension,hyperlipidemia, hyperglycemia were compared. While FBG, TC, TG, HDL-C LDL-C, SBP, DBP, BMI levels were compared between the two groups. Results Among 1420 volunteers, 211 cases suffered with fatty liver, accounted for14.86%. 170 cases of male, the prevalence rate was 16.63%, 41 cases of female, the prevalence rate was 10.30%; the prevalence of fatty liver in males was significantly higher than female(χ2=13.478, P 0.05). Prevalence rates of fatty liver in males aged 30-40 and 40-50 were 20.00%, 20.14% retrospectively, significantly higher than other age groups(P 0.05); which in female aged 40-50, 50-60 were 12.67% and 11.58% retrospectively, significantly higher than other age groups(P 0.05). Incidence of hypertension, hyperlipidemia, hyperglycemia in fatty liver group were significantly higher than the non- fatty liver group, the differences were statistically significant between two groups(P 0.05). The FBG, TC, TG, LDL-C, SBP, DBP, BMI levels in fatty liver group were significantly higher than the non-fatty liver group, but the HDL-C level in the fatty liver group was lower, the differences were statistically significant(P 0.05). Conclusion Fatty liver has close relationship with hypertension, hyperlipidemia, hyperglycemia. These indicators should be combined analyzed in clinic, thus providing basis for guiding the development of integrated control measures.
Key concepts: Medicine, Fatty liver, Hyperlipidemia, Internal medicine, Incidence (geometry), Gastroenterology, Endocrinology, Diabetes mellitus